Ultralife Vs. Aligos Therapeutics Industry Stock Comparison

Sell

39

ULBI
Ultralife

Last Price:

$7.36

Seasonality Move:

8.62%

Buy

62

ALGS
Aligos Therapeutics

Last Price:

$33.58

Seasonality Move:

-18.25%

Sell

39

Ultralife (ULBI) is a Sell

Is Ultralife a Buy, Sell or Hold?

The current Ultralife [ULBI] share price is $7.39. The Score for ULBI is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
ULBI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

62

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

The current Aligos Therapeutics [ALGS] share price is $38.39. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ULBI Stock Price Chart

What is Ultralife's stock price today?

The Ultralife share price today is $7.39

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ULBI is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

The Aligos Therapeutics share price today is $38.39

The current trend is moderately bearish and ALGS is experiencing slight selling pressure.

ULBI Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.1	Sell
Relative Strength Index (14 RSI):	44.02	Sell
Chaikin Money Flow:	-4707	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.34 - 7.78)	Sell
Bollinger Bands (100):	(7.63 - 9.75)	Sell

ALGS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	4.47	Buy
Relative Strength Index (14 RSI):	56.78	Buy
Chaikin Money Flow:	-32589	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(30.39 - 41.59)	Buy
Bollinger Bands (100):	(6.9 - 29.68)	Buy

ULBI Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	7.44	Sell
20-day SMA:	7.52	Sell
50-day SMA:	7.82	Sell
200-day SMA:	9.65	Sell
8-day EMA:	7.47	Sell
20-day EMA:	7.52	Sell
50-day EMA:	7.88	Sell
200-day EMA:	8.83	Sell

ALGS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	41.2	Sell
20-day SMA:	38.15	Buy
50-day SMA:	25.97	Buy
200-day SMA:	17.23	Buy
8-day EMA:	40.71	Sell
20-day EMA:	37.37	Buy
50-day EMA:	29.03	Buy
200-day EMA:	19.88	Buy

Ultralife Earnings Growth & ULBI Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Ultralife Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3	Jan 6	Jan 7	Jan 8
	Dec						Jan
	24	26	27	30	31	02	03	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):